Bajaj Finserv Limited:企業の戦略・SWOT・財務情報

◆英語タイトル:Bajaj Finserv Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1148
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Bajaj Finserv Limited – Strategy, SWOT and Corporate Finance Report
Summary

Bajaj Finserv Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Bajaj Finserv Limited (BFS) is a financial services holding company. The company offers a range of consumer finance, SME finance, commercial lending, insurance and wealth management products and services to individuals and corporate clients. Its offerings include personal loans, consumer durable loans, small business loans, construction equipment loans, loans against property and shares, two- and three-wheeler financing, and advisory and investment planning services. It also provides infrastructure financing focusing on roads, telecom, power, railway, ports and associated sectors. It offers insurance products, including life insurance, health insurance, auto insurance, travel insurance, property insurance and commercial insurance. The company operates through its subsidiaries and branch offices in India. BFS is headquartered in Pune, Maharashtra, India.

The company reported insurance premium of INR135,463.4 million for fiscal year ended March 2018 ( FY2018), an increase of 22.5% over that in FY2017.

Scope

- Detailed information on Bajaj Finserv Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Bajaj Finserv Limited in the form of a SWOT analysis
- An in-depth view of the business model of Bajaj Finserv Limited including a breakdown and examination of key business segments
- Intelligence on Bajaj Finserv Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Bajaj Finserv Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Bajaj Finserv Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Bajaj Finserv Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Bajaj Finserv Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Bajaj Finserv Limited: Company Overview 9
Bajaj Finserv Limited: Overview and Key Facts 9
Bajaj Finserv Limited: Overview 9
Bajaj Finserv Limited: Key Facts 9
Bajaj Finserv Limited: Key Employees 11
Bajaj Finserv Limited: Key Employee Biographies 12
Bajaj Finserv Limited: Major Products and Services 13
Bajaj Finserv Limited: Company History 14
Bajaj Finserv Limited: Management Statement 15
Bajaj Finserv Limited: Locations and Subsidiaries 17
Bajaj Finserv Limited: Key Competitors 19
Bajaj Finserv Limited: Company Analysis 20
Bajaj Finserv Limited: Business Description 20
Bajaj Finserv Limited: SWOT Analysis 21
Bajaj Finserv Limited: SWOT Overview 21
Bajaj Finserv Limited: Strengths 21
Bajaj Finserv Limited: Weaknesses 22
Bajaj Finserv Limited: Opportunities 22
Bajaj Finserv Limited: Threats 22
Bajaj Finserv Limited: Corporate Financial Deals Activity 24
Bajaj Finserv Limited: Financial Deals Overview 24
Bajaj Finserv Limited: Targets and Partners 25
Bajaj Finserv Limited: Top Deals 2014 – 2018YTD* 26
Bajaj Finserv Limited: Mergers and Acquisitions 27
Bajaj Finserv Limited: Partnership 28
Bajaj Finserv Limited: Recent Developments 29
Bajaj Finserv Limited: News and Events Summary 29
Bajaj Finserv Limited: Business Expansion 29
Bajaj Finserv Limited: Contracts 30
Bajaj Finserv Limited: Financial Deals 30
Bajaj Finserv Limited: Financial Performance 30
Appendix 32
Contact Us 32
Methodology 32
About MarketLine 33

List of Tables
Table 1: Bajaj Finserv Limited: Key Facts
Table 2: Bajaj Finserv Limited: Key Employees
Table 3: Bajaj Finserv Limited: Locations and Subsidiaries
Table 4: Bajaj Finserv Limited: Key Competitors
Table 5: Bajaj Finserv Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Bajaj Finserv Limited: M&A Average Deal Size - Value (US$m)
Table 7: Bajaj Finserv Limited: Targets and Partners
Table 8: Bajaj Finserv Limited: Top Deals 2014 - 2018YTD*
Table 9: Bajaj Finserv Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Bajaj Finserv Limited: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Bajaj Finserv Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 12: Bajaj Finserv Limited: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 13: Bajaj Finserv Limited: News and Events Summary
Table 14: Bajaj Finserv Limited: Business Expansion
Table 15: Bajaj Finserv Limited: Contracts
Table 16: Bajaj Finserv Limited: Financial Deals
Table 17: Bajaj Finserv Limited: Financial Performance

List of Figures
Figure 1: Bajaj Finserv Limited: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Bajaj Finserv Limited: M&A Average Deal Size - Value (US$m)
Figure 3: Bajaj Finserv Limited: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Bajaj Finserv Limited: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Bajaj Finserv Limited: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 6: Bajaj Finserv Limited: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Bajaj Finserv Limited:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • South Texas Accelerated Research Therapeutics:製薬・医療:M&Aディール及び事業提携情報
    Summary South Texas Accelerated Research Therapeutics (START) accelerates the development of novel anticancer agents that improves personalized and clinical care for cancer patients. The company offers preclinical and clinical research services which include pharmacokinetics, in vivo and in vitro se …
  • Avaya Inc:企業の戦略的SWOT分析
    Avaya Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Manz AG (M5Z):電力:M&Aディール及び事業提携情報
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • The Chugoku Bank Ltd:企業の戦略・SWOT・財務情報
    The Chugoku Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Chugoku Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Verastem Inc (VSTM):企業の財務・戦略的SWOT分析
    Summary Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-55 …
  • Oxurion NV (THR):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxurion NV(Oxurion) formerly known as ThromboGenics NV, is a biotechnology company, which develops and commercializes ophthalmic and cancer medicines. The company’s ocriplasmin, a recombinant derivative of the plasmin protein, is commercialized as Jetrea in the US to treat symptomatic vitreo …
  • Integra LifeSciences Holdings Corp (IART):医療機器:M&Aディール及び事業提携情報
    Summary Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company’s portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, o …
  • Peet’s Coffee & Tea Inc:企業の戦略・SWOT・財務情報
    Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report Summary Peet's Coffee & Tea Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • American Axle & Manufacturing Holdings, Inc.
    American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Axle & Manufacturing Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operati …
  • Country Club Hospitality & Holidays Ltd.:企業の戦略・SWOT・財務分析
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Geistlich Pharma AG:企業の戦略的SWOT分析
    Geistlich Pharma AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Prismic Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Prismic Pharmaceuticals Inc (Prismic Pharmaceuticals) is a specialty pharmaceutical company that offers development of prescription drugs. The company offers research and development programs for prescription product candidates and provides unique safety profiles. It develops drugs for infla …
  • Tragara Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tragara Pharmaceuticals Inc (Tragara Pharmaceuticals) is a pharmaceutical company focused on the clinical and commercial development of its proprietary medicines for the treatment of various cancers. Its lead product candidate TG02, an oral multi-kinase inhibitor facilitates anti-tumor activ …
  • Spherix Inc (SPEX)
    Spherix Inc (SPEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Jones Lang LaSalle Inc (JLL):企業の財務・戦略的SWOT分析
    Jones Lang LaSalle Inc (JLL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Terumo BCT Inc:企業の戦略的SWOT分析
    Terumo BCT Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • HPQ Silicon Resources Inc (HPQ):企業の財務・戦略的SWOT分析
    Summary HPQ Silicon Resources Inc (HPQ Silicon), formerly Uragold Bay Resources, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, production and development of silicon, gold and quartz properties, among others. It holds interests in The B …
  • Blue Cross and Blue Shield Association:企業の戦略的SWOT分析
    Blue Cross and Blue Shield Association - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Boustead Heavy Industries Corp Bhd:企業の戦略・SWOT・財務分析
    Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report Summary Boustead Heavy Industries Corp Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • EyePoint Pharmaceuticals Inc (PSDV):製薬・医療:M&Aディール及び事業提携情報
    Summary EyePoint Pharmaceuticals Inc (EyePoint), formerly pSivida Corp, is a biopharmaceutical company that provides development of miniaturized, sustained-release drug delivery products and technologies. The company offers products such as iluvien, retisert and durasert, among others. Its durasert …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆